We are live on
!
Find out more
Vanguard Group Portfolio holdings
AUM
$6.9T
1-Year Est. Return
27.45%
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
This Fund
S&P 500
This Quarter
Est. Return
+9.84%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$3.67T
AUM Growth
+$273B
(+8%)
Cap. Flow
+$30.8B
Cap. Flow
% of AUM
0.84%
Top 10 Holdings %
Top 10 Hldgs %
18.2%
Holding
4,644
New
41
Increased
3,402
Reduced
945
Closed
112
Avg Time Held
25.8
quarters
Top 10 Avg Time Held
18.2
quarters
Top 20 Avg Time Held
19.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$2.67B |
| 2 |
Ferguson
FERG
|
+$2.17B |
| 3 |
Atlassian
TEAM
|
+$2.04B |
| 4 |
Microsoft
MSFT
|
+$2.02B |
| 5 |
Amazon
AMZN
|
+$1.04B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$3.16B |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$2.44B |
| 3 |
CTXS
Citrix Systems Inc
CTXS
|
+$1.51B |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$1.29B |
| 5 |
Y
Alleghany Corp
Y
|
+$1.03B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.66% |
| 2 | Healthcare | 14.85% |
| 3 | Financials | 14.17% |
| 4 | Industrials | 9.67% |
| 5 | Consumer Discretionary | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4326
Artelo Biosciences
ARTL
$1.79M
| $181K | ﹤0.01% |
386
-53
| -12% | -$24.9K |
2021 Q1
7 quarters
|
|
|
NBSE
4327
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $180K | ﹤0.01% |
47,284
-5,669
| -11% | -$29.1K |
2013 Q3
37 quarters
|
|
|
PWCM
4328
PowerCompute Inc
PWCM
$1.55M
| $177K | ﹤0.01% |
2,144
-1
| -0% | -$119 |
2019 Q1
15 quarters
|
|
|
APGN
4329
DELISTED
Apexigen, Inc. Common Stock
APGN
| $175K | ﹤0.01% |
256,935
+380
| +0.1% | +$741 |
2022 Q3
1 quarter
|
|
|
BBLN
4330
DELISTED
Babylon Holdings Limited
BBLN
| $175K | ﹤0.01% |
25,918
+6,133
| +31% | +$71.6K |
2022 Q2
2 quarters
|
|
|
GTH
4331
DELISTED
Genetron Holdings Limited ADS
GTH
| $174K | ﹤0.01% |
51,741
-193,344
| -79% | -$531K |
2021 Q3
5 quarters
|
|
|
YTEN
4332
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
| $173K | ﹤0.01% |
4,311
+4
| +0.1% | +$238 |
2021 Q1
7 quarters
|
|
4333
iPower
IPW
$858K
| $172K | ﹤0.01% |
199
| – | – |
2021 Q3
5 quarters
|
|
|
APCX
4334
DELISTED
AppTech Payments
APCX
| $171K | ﹤0.01% |
+72,000
| New | +$66.5K |
2022 Q4
0 quarters
|
|
|
BIOL
4335
DELISTED
Biolase, Inc.
BIOL
| $170K | ﹤0.01% |
2,615
-137
| -5% | -$19.7K |
2013 Q2
38 quarters
|
|
4336
Nephros
NEPH
$38.3M
| $170K | ﹤0.01% |
146,685
-1,098
| -0.7% | -$1.17K |
2020 Q1
11 quarters
|
|
|
IPM
4337
Intelligent Protection Management Corp
IPM
$23.1M
| $169K | ﹤0.01% |
127,973
+67
| +0.1% | +$100 |
2021 Q4
4 quarters
|
|
4338
Duos Technologies
DUOT
$227M
| $168K | ﹤0.01% |
83,910
+67
| +0.1% | +$199 |
2021 Q2
6 quarters
|
|
|
FEED
4339
DELISTED
ENVUE MEDICAL INC NEW
FEED
| $164K | ﹤0.01% |
25
| – | – |
2021 Q1
7 quarters
|
|
4340
Creative Realities
CREX
$32.2M
| $159K | ﹤0.01% |
91,631
+177
| +0.2% | +$324 |
2019 Q3
13 quarters
|
|
4341
Generation Income Properties
GIPR
$1.27M
| $158K | ﹤0.01% |
3,262
| – | – |
2022 Q2
2 quarters
|
|
4342
Laird Superfood
LSF
$32.7M
| $156K | ﹤0.01% |
186,227
| – | – |
2020 Q3
9 quarters
|
|
|
IVF
4343
INVO Fertility Inc
IVF
$1.82M
| $156K | ﹤0.01% |
13
| – | – |
2021 Q1
7 quarters
|
|
4344
Data Storage Corp
DTST
$7.81M
| $154K | ﹤0.01% |
103,997
+98
| +0.1% | +$186 |
2021 Q3
5 quarters
|
|
|
CALA
4345
DELISTED
Calithera Biosciences, Inc
CALA
| $154K | ﹤0.01% |
47,169
-94,048
| -67% | -$225K |
2014 Q4
32 quarters
|
|
|
OYST
4346
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $151K | ﹤0.01% |
13,500
-413,595
| -97% | -$4.01M |
2019 Q4
12 quarters
|
|
|
PFIN
4347
DELISTED
P&F Industries
PFIN
| $149K | ﹤0.01% |
29,463
+373
| +1% | +$1.95K |
2014 Q1
35 quarters
|
|
4348
Tenon Medical
TNON
$2.27M
| $148K | ﹤0.01% |
33
+7
| +27% | +$35.7K |
2022 Q2
2 quarters
|
|
|
ID
4349
DELISTED
PARTS iD, Inc.
ID
| $144K | ﹤0.01% |
147,426
+1,600
| +1% | +$2.19K |
2021 Q1
7 quarters
|
|
|
EZRA
4350
Reliance Global Group
EZRA
$3.28M
| $143K | ﹤0.01% |
25
| – | – |
2021 Q1
7 quarters
|
|
Similar funds
CWM
FAF
BGIM
CIM
UOC
Vanguard Group's Q4 2022 Portfolio in Review
As of Q4 2022, Vanguard Group held 4,644 positions worth $3.67T, up 8% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2022: portfolio turnover was 3.3%. Vanguard Group opened 41 new positions and exited 112, leaving the 4,644-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- Vanguard Group's largest Q4 2022 buy was U-Haul Holding Co Series N: 8,844,620 shares worth $486M.
- Vanguard Group added most to Prologis in Q4 2022, an estimated $2.67B increase.
- Vanguard Group's biggest Q4 2022 reduction was McKesson, cutting an estimated $868M.
- Vanguard Group fully exited Twitter, Inc. in Q4 2022, selling an estimated $3.16B.
- Vanguard Group's ten largest holdings make up 18% of its $3.67T portfolio in Q4 2022.
- Vanguard Group opened 41 new positions and closed 112 in Q4 2022.
- Vanguard Group's portfolio value rose 8% quarter-over-quarter to $3.67T.
Based on Vanguard Group's 13F filing for Q4 2022, filed 10 Feb 2023.